Your browser doesn't support javascript.
loading
Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity.
Brandão, Mariana; Bariani, Riccardo; Rigato, Ilaria; Bauce, Barbara.
  • Brandão M; Cardiology Department, Centro Hospitalar Vila Nova de Gaia/Espinho, 4430-000 Vila Nova de Gaia, Portugal.
  • Bariani R; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35122 Padova, Italy.
  • Rigato I; Azienda Ospedaliera/Universita' di Padova, Via Giustiniani, 2-Padova, 35128 Padova, Italy.
  • Bauce B; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35122 Padova, Italy.
J Clin Med ; 12(7)2023 Apr 03.
Article en En | MEDLINE | ID: mdl-37048743
ABSTRACT
Desmoplakin (DSP) is a desmosomal protein that plays an essential role for cell-to-cell adhesion within the cardiomyocytes. The first association between DSP genetic variants and the presence of a myocardial disease referred to patients with Carvajal syndrome. Since then, several reports have linked the DSP gene to familial forms of arrhythmogenic (ACM) and dilated cardiomyopathies. Left-dominant ACM is the most common phenotype in individuals carrying DSP variants. More recently, a new entity-"Desmoplakin cardiomyopathy"-was described as a distinct form of cardiomyopathy characterized by frequent left ventricular involvement with extensive fibrosis, high arrhythmic risk, and episodes of acute myocardial injury. The purpose of this review was to summarize the available evidence on DSP cardiomyopathy and to identify existing gaps in knowledge that need clarification from upcoming research.
Palabras clave